OXTR and Parkinson disease: Indeed, the activation of the OTR and blockade of the A2A receptor in the receptor complex in PD might contribute to the rescue of the control of glutamate extracellular levels and the impaired anti-neuroinflammatory effect resulting from the defective activation of astrocytic D2 receptors.